Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

Clinical trial NCT04071236 · SUSPENDED

Trial details

NCT number: NCT04071236
Sponsor: National Cancer Institute (NCI)
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Carcinoma Metastatic Malignant Neoplasm in the Bone Metastatic Malignant Neoplasm in the Lymph Nodes Stage IVB Prostate Cancer AJCC v8

Start date: 2020-10-14
Primary completion: 2027-04-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.